SCHEMBL3115778

SCHEMBL3115778

C=CCn1c(Cl)nc2c1c(=O)n(CCCCO)c(=O)n2CCCC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.52
CYP2C19 P33261 2/20 0.52
RECQL P46063 1/20 0.52
USP2 O75604 1/20 0.43
HTT P42858 3/20 0.42
LMNA P02545 2/20 0.42
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
GALR3 O60755 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
RAB9A P51151 1/20 0.41
PDE4A P27815 6/20 0.41
PDE4B Q07343 6/20 0.41
PDE4C Q08493 6/20 0.41
PDE4D Q08499 6/20 0.41
ADORA2B P29275 4/20 0.41
ADORA2A P29274 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL836842 0.96 CYP1A2 (0.53) CYP1A2CYP2C19RECQLUSP2HTT
SCHEMBL13247924 0.94 CYP1A2 (0.58) CYP1A2CYP2C19RECQLUSP2HTT
SCHEMBL836600 0.92 CYP1A2 (0.47) CYP1A2CYP2C19RECQLUSP2HTT
SCHEMBL16027932 0.89 CYP1A2 (0.44) CYP1A2CYP2C19RECQLUSP2HTT
SCHEMBL16076197 0.89 CYP1A2 (0.55) CYP1A2CYP2C19RECQLUSP2HTT
SCHEMBL3108479 0.87 CYP1A2 (0.51) CYP1A2CYP2C19RECQLUSP2HTT
SCHEMBL17993315 0.85 CYP1A2 (0.67) CYP1A2CYP2C19RECQLUSP2HTT
SCHEMBL13247692 0.85 USP2 (0.43) CYP1A2CYP2C19RECQLUSP2HTT
SCHEMBL3188422 0.84 CYP1A2 (0.62) CYP1A2CYP2C19RECQLUSP2HTT
SCHEMBL835479 0.84 CYP1A2 (0.50) CYP1A2CYP2C19RECQLUSP2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100179128-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS SMITHKLINE BEECHAM CORPORATION 2010-07-15 US disclosed
US-20100179128-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS SMITHKLINE BEECHAM CORPORATION 2010-07-15 US disclosed
US-20100179128-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS SMITHKLINE BEECHAM CORPORATION 2010-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179128-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS XDH, GPR84, GPR88 CYP1A2 255/4885CYP2C19 914/4885RECQL 2283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.